Showing results (1931-1940 of 1,952) with videos related to
Sort By:
Pageof 196
Journal of Korean Medical Science|May 14, 2024
Impact of COVID-19 Infection and Its Association With Previous Vaccination in Patients With Myasthenia Gravis in Korea: A Multicenter Retrospective StudyHee Jo Han, Seung Woo Kim, Hyunjin Kim, et al.Annals of Hematology|May 28, 2016
Cytogenetic profiles of 2806 patients with acute myeloid leukemia-a retrospective multicenter nationwide studyJa Min Byun, Young Jin Kim, Hwi-Joong Yoon, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 2, 2023
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrumSu Yeon Park, Young Nam Kwon, Sunyoung Kim, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2025
Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON StudyJin-Ji Yang, Yu Mu, Zhe-Hai Wang, et al.Nature Communications|December 15, 2023
Maternal dominance contributes to subgenome differentiation in allopolyploid fishesMin-Rui-Xuan Xu, Zhen-Yang Liao, Jordan R Brock, et al.World Journal of Pediatrics : WJP|August 14, 2024
Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in childrenYing-Shuo Wang, Yun-Lian Zhou, Guan-Nan Bai, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2025
Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated diseaseYou-Ri Kang, Hyunjin Ju, Ki Hoon Kim, et al.Neurology|March 12, 2026
Prevalence and Relative Proportions of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the Republic of KoreaSu-Hyun Kim, Eun-Jae Lee, Young-Min Lim, et al.Leukemia & Lymphoma|April 6, 2011
Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemiaSang Kyun Sohn, Suk Joong Oh, Byung Soo Kim, et al.Nature Communications|February 5, 2023
Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significanceMei Lin, Xiao-Long Zhang, Rui You, et al.Pageof 196